ArticleEuropean journal of public health2025
Heart failure burden in Kazakhstan among adults: data from Unified National Electronic Healthcare System 2014-19.
Article in European journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Heart failure (HF) is a complex clinical syndrome with significant mortality risks, causing an increasing healthcare burden. Globally, 64.3 million prevalent cases were estimated in 2017. This research examines HF epidemiology in the adult population in Kazakhstan, the largest country in Central Asia. The retrospective analysis was performed on data from the Unified National Electronic Health System, involving 526 766 individuals registered with HF between 2014 and 2019. In the cohort, women accounted for 54% and men for 46%, and the majority (87%) were aged 50 or above. The most prevalent comorbid conditions were hypertension (46%), cerebrovascular diseases (32%), and atherosclerotic heart disease (23%). While the incidence rate declined over the observation period, the all-cause mortality rate almost tripled from 356 to 975 people per million population during the observation period. Of the cohort, 14% of the patients (71 591) were recorded as deceased. In 2019, HF in Kazakhstan resulted in the loss of 2364789.8 disability-adjusted life years. Premature death accounted for a major portion, with 1337578.9 years of life lost. Males have a higher risk of death compared to females [hazard ratio (HR) = 1.24, 95% confidence interval (CI): 1.23-1.26]. History of acute myocardial infarction increases the risk of death by 69% (HR = 1.69, 95% CI: 1.67-1.73) and diabetes by 14% (HR = 1.14, 95% CI: 1.12-1.16) after adjustment for other variables. This research evaluated the burden and disability-adjusted life years of HF in Kazakhstan. The results show that more effective disease management systems and preventive measures for the elderly are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.